Our group has previously reported MSI and RAS/BRAF status as well as immune cell score in a subset of this patient series [41,42] and, therefore, MSI and RAS/BRAF status as well as detailed histopathological tumor characteristics were not addressed here. Here, BRAF is linked to neoplasm.